IPP Bureau
Aster DM Healthcare appoints Dr. Nitish Shetty as India CEO
By IPP Bureau - March 18, 2023
He is Proficient in overseeing and leading teams for running successful business operations
Drug coated balloons is an alternative to stents in younger patients: Experts
By IPP Bureau - March 18, 2023
This is especially the case if the patients are young, have multiple blocks & have conditions that may make angioplasty to implant drug-eluting stents ineffective
Briefs: Man Industries, Jeevan Scientific Technology, Unichem and Torrent Pharmaceuticals
By IPP Bureau - March 18, 2023
Man Industries (India) Limited has received a new export order of approximately Rs. 1,300 crores.
Jubilant receives additional CAD 23.8 million loan facility for CMO Montreal facility
By IPP Bureau - March 17, 2023
This loan is in addition to earlier announced CAD 25 million loan committed by the Province of Quebec
Dr. Reddy's divests non-core brands in dermatology to Eris Lifesciences for Rs 275 Cr
By IPP Bureau - March 17, 2023
Eris Lifesciences will be assigned the trademark of these brands by Dr. Reddy's for a consideration of Rs. 275 crore
Mindset Pharma to defend against lawsuit filed by Reunion Neurosciences
By IPP Bureau - March 17, 2023
Mindset disagrees with and denies the allegations set forth from Reunion.
ICMR approves Krivida Trivus to detect Influenza, SARS CoV2, and RSV
By IPP Bureau - March 17, 2023
KRIVIDA TRIVUS detects the specific virus causing a respiratory infection.
Ayush Ministry signs MoU with Ministry of Rural Development to empower the rural youth
By IPP Bureau - March 17, 2023
The collaboration between both the ministries will play an important role in enhancing the skill and service sector related to Ayurveda
India can lead the “One Earth, One Health” vision, says Minister Mandaviya
By IPP Bureau - March 16, 2023
“One Earth, One Health” vision can become a reality only with active global collaboration where countries don’t think of only themselves, but of collective global outcomes
2654 compounds screened for different activities for GPCR profiling: Dr Jitendra Singh
By IPP Bureau - March 16, 2023
MoES have identified a potent Anti-cancer molecule named GS/IICT5/6
Apollo Hospitals crosses the landmark of 10,000+ robotic surgeries
By IPP Bureau - March 16, 2023
Expands robotics to 20+ specialities
Biocorp and HRA Pharma to jointly develop a medical device innovation
By IPP Bureau - March 16, 2023
Biocorp will receive an initial milestone payment this year
PCI Pharma plans Biologics assembly facility in the Midwest
By IPP Bureau - March 16, 2023
New Building at Rockford, Illinois site will significantly increase equipment and capacity for injectable biologics and other self-administered therapies
Glenmark Pharmaceuticals receives ANDA approval for Clindamycin Hydrochloride Capsules USP
By IPP Bureau - March 15, 2023
Cleocin Hydrochloride Capsules market achieved annual sales of approximately US $33.6 million
RTsafe announces first use of its PseudoPatient patient-specific quality assurance process
By IPP Bureau - March 15, 2023
Spain’s renowned centre of excellence recognises importance of verifying radiosurgery plans ahead of patient treatment
